Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 19, 2020 - Issue 4: Dermatology
Submit an article Journal homepage
390
Views
12
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

Safety update of etanercept treatment for moderate to severe plaque psoriasis

Anna CampanatiDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, ItalyCorrespondence[email protected]
View further author information
,
Federico DiotalleviDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, ItalyView further author information
,
Emanuela MartinaDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, ItalyView further author information
,
Matteo PaolinelliDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, ItalyView further author information
,
Giulia RadiDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, ItalyView further author information
&
Annamaria OffidaniDermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, ItalyView further author information
Pages 439-448 | Received 16 Dec 2019, Accepted 05 Mar 2020, Published online: 19 Mar 2020

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Lluís Rusiñol, Elena Carmona-Rocha & Lluís Puig. (2023) Durability and long-term outcomes of biologic therapies in psoriasis. Expert Review of Clinical Immunology 0:0, pages 1-12.
Read now
Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini & Luca Potestio. (2023) Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients. Expert Opinion on Drug Safety 22:1, pages 43-58.
Read now
Matteo Megna, Luca Potestio, Gabriella Fabbrocini & Elisa Camela. (2022) Treating psoriasis in the elderly: biologics and small molecules. Expert Opinion on Biological Therapy 22:12, pages 1503-1520.
Read now

Articles from other publishers (9)

Yang Song, Lei Yao, Shanshan Li & Junfeng Zhou. (2023) Psoriasis comorbidity management in the COVID era: a pressing challenge. Frontiers in Microbiology 14.
Crossref
Darshani Patil, Ajazuddin & Sankha Bhattacharya. (2023) Insight of Engineered Nano-based Biologics Approaches used to Combat Autoimmune Disease using TNF-α & IL Inhibitors. Current Topics in Medicinal Chemistry 23:19, pages 1793-1806.
Crossref
Xiaomei Liu, Zelan Yang, Chenglong Liu, Bo Xu, Xueqing Wang, Yang Li, Jing Xia, Danni Li, Can Zhang, Hui Sun & Qing Yang. (2023) Identification of a type II LacNAc specific binding lectin CMRBL from Cordyceps militaris. International Journal of Biological Macromolecules 230, pages 123207.
Crossref
Federico Diotallevi, Oriana Simonetti, Giulio Rizzetto, Elisa Molinelli, Giulia Radi & Annamaria Offidani. (2022) Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives. International Journal of Molecular Sciences 23:19, pages 11128.
Crossref
Federico Diotallevi, Anna Campanati, Giulia Radi, Emanuela Martina, Giulio Rizzetto, Pamela Barbadoro, Marcello Mario D’Errico & Annamaria Offidani. (2021) Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy. Dermatology and Therapy 11:6, pages 1889-1903.
Crossref
Jiangluyi Cai, Lian Cui, Yu Wang, Ying Li, Xilin Zhang & Yuling Shi. (2021) Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis. Frontiers in Pharmacology 12.
Crossref
Giovanni Paolino, Santo Raffaele Mercuri, Pietro Bearzi & Carlo Mattozzi. (2020) Systemic immunobiological, immunosuppressant, and oncologic agents for the treatment of dermatologic diseases during the SARS‐CoV ‐2 ( COVID‐19 ) pandemic emergency: A quick review for a quick consultation . Dermatologic Therapy 33:5.
Crossref
A. Campanati, V. Brisigotti, F. Diotallevi, G.M. D’Agostino, M. Paolinelli, G. Radi, G. Rizzetto, C. Sapigni, C. Tagliati & A. Offidani. (2020) Active implications for dermatologists in ‘SARS‐CoV‐2 ERA’: Personal experience and review of literature. Journal of the European Academy of Dermatology and Venereology 34:8, pages 1626-1632.
Crossref
Jiun-Wen Guo, Yu-Pin Cheng, Chih-Yi Liu, Haw-Yueh Thong, Chi-Jung Huang, Yang Lo, Chen-Yu Wu & Shiou-Hwa Jee. (2020) Salvianolic Acid B in Microemulsion Formulation Provided Sufficient Hydration for Dry Skin and Ameliorated the Severity of Imiquimod-induced Psoriasis-like Dermatitis in Mice. Pharmaceutics 12:5, pages 457.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.